Skin MelanomaMesurNCT07251335
Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active Search and Prevention of Occupational Diseases Based on Recent INAIL Criteria
An observational study of Skin Melanoma and Cutaneous Melanoma, run by University of Modena and Reggio Emilia at 1 site in Italy.
Trial summary
The goal of this observational study is to learn about the link between work-related sun exposure and a specific type of skin cancer called melanoma in people living in the Modena area, Italy. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Skin Melanoma, Cutaneous Melanoma
- How many people
- 300 participants
- Where
- 1 siteItaly
- Study dates
- 7 Jul 2025to Nov 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population will be selected from the patient cohort attending the Dermatology Clinic of the University Hospital of Modena (Azienda Ospedaliero-Universitaria di Modena), Italy. This clinic serves a large number of citizens from the Modena province and surrounding areas each year, providing a representative sample for investigating skin cancer. Participants will be identified from among those referred to the clinic for the examination and diagnosis of suspicious pigmented skin lesions.
Who may be able to join
- Be a patient of the Dermatology Clinic at the University Hospital of Modena.
- Be 18 years of age or older.
- Have undergone a dermatological screening for a suspected skin lesion.
- Be able to understand and sign an informed consent form in italian language.
Who cannot join
- Be under 18 years of age.
- Have cognitive impairment that prevents providing reliable answers to the interview or recalling past exposures.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site, 1 recruiting
- Recruiting
Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze
Modena, Mo, 41122
Alberto Modenese, MD, PhD, +39 059 205 5461, alberto.modenese@unimore.it
Angela Contri, PhD, +39 059 205 5463, angela.contri@libero.it
About this study
The goal of this observational study is to learn about the link between work-related sun exposure and a specific type of skin cancer called melanoma in people living in the Modena area, Italy.
The main questions it aims to answer are:
Read more
- Is there a connection between working outdoors and developing types of melanoma that are linked to long-term sun exposure?
- Can we use recent criteria from the Italian workers' compensation authority (Istituto Nazionale per l'Assicurazione contro gli Infortuni sul Lavoro, INAIL) to better identify and report these melanomas as occupational diseases?
Participants in this study will:
- Be patients of the Modena University Hospital Dermatology Clinic who are already undergoing a skin biopsy for a suspected lesion.
- Take part in a one-time interview with a trained healthcare worker.
Answer questions about their:
- Job history and specific work locations (to calculate local UVR exposure).
- Sun exposure habits at work and in their free/holiday time.
- Use of sun protection (e.g., sunscreen, protective clothing).
- Use of tanning beds.
- Natural skin color and tendency to sunburn (and other elements to determine their specific skin phototype).
- Other personal and family health factors.
Researchers will compare two groups:
- Cases: 120 participants who are diagnosed with melanoma after the biopsy.
- Controls: 180 participants who screened negative for melanoma but may show another skin condition.
By comparing these groups, researchers aim at better understanding the role of outdoor work as a risk factor for specific melanoma subtypes. For participants diagnosed with a melanoma that is likely linked to their job, the study team will promote its reporting as an occupational disease.
Read the detailed description
This is a monocentric, observational, case-control study conducted at the Dermatology Clinic of the University Hospital of Modena (Azienda Ospedaliero-Universitaria di Modena), Italy.
Background and Rationale:
Skin melanoma is a significant public health concern. While its link to solar ultraviolet radiation (UVR) is established, the specific role of occupational (long-term, cumulative) exposure, as opposed to recreational (intermittent, intense) exposure, is still a subject of detailed investigation. In the period 2008-2014, skin melanoma was included in List 2 (limited probability of occupational origin) of diseases to be mandatorily reported as "occupational" by physicians (Italian law DPR 1124/1965) for the exposure agent "solar radiation". After 2014, it was removed from that list, partly due to evolving scientific evidence suggesting that UV-related malignant melanoma was more strongly related to a pattern of solar ultraviolet radiation exposure typically associated with leisure time activities rather than occupational outdoor activities, especially during childhood and adolescence. Recent classifications by the World Health Organization (WHO) now distinguish melanoma subtypes based on their association with cumulative solar damage (CSD). This is a crucial development, as occupational outdoor activity is a primary factor associated with cumulative sun damage. A joint WHO/International Labour Organization (ILO) meta-analysis found a significantly increased risk for one specific CSD-related subtype, Lentigo Maligna Melanoma, in outdoor workers. In line with this, the Italian National Institute for Insurance against Accidents at Work (Istituto Nazionale per l'Assicurazione contro gli Infortuni sul Lavoro, INAIL) has recently proposed new criteria for recognizing specific CSD-related melanomas as occupational diseases in this worker population.
This study aims to apply these novel criteria in a clinical setting to investigate the association between occupational UVR exposure and CSD-related melanoma subtypes.
Study Objectives:
- The primary objective is to evaluate the association between occupational solar UVR exposure and the risk of developing melanoma, with a specific focus on subtypes related to cumulative solar damage (CSD).
Secondary objectives include:
- Comparing occupational and recreational UVR exposure patterns between melanoma cases and controls.
- Correlating melanoma subtypes (CSD-related vs. non-CSD-related) and their body location with specific UVR exposure histories.
- Applying the recent INAIL criteria to identify cases of melanoma that qualify for reporting as occupational diseases.
- Quantitatively estimating individual occupational UVR exposure levels by applying a validated European job-exposure matrix (JEM) developed by Würtz et al. in 2025.
- Calculating and comparing an individualised melanoma risk score for each participant, based on established non-occupational risk factors, according to the model developed and externally validated by Fortes et al. in 2010.
- Analysing the relationship between quantitative occupational UVR exposure and the individualised melanoma risk score.
Study Population and Recruitment:
The study population will consist of patients referred to the Dermatology Clinic for examination of suspicious skin lesions. All enrolled participants will provide written informed consent.
Cases: Approximately 120 adult patients (≥18 years) with a new, histopathologically confirmed diagnosis of cutaneous melanoma.
Controls: Approximately 180 adult patients (≥18 years) who undergo a dermatological screening for a suspicious lesion, but for whom the result of the screening is negative for melanoma. These controls will be matched to cases based on similar age and gender to minimize confounding.
Methods:
Data Collection: After enrolment, all participants (cases and controls) will undergo a single, structured interview conducted by trained healthcare personnel (e.g., resident physicians). The interview will use a detailed questionnaire designed specifically for this study based on a comprehensive literature review.
Questionnaire Content: The questionnaire will collect data on:
- Socio-demographics and general information: Age, gender, country of birth, smoking habits, physical characteristics linked to determine phototype, ease of sunburn, residential history.
- Dermatological anamnesis: Skin melanoma diagnosis, type of melanoma, location, past diagnosis of skin melanoma(ta) and location, past diagnosis of non-melanoma(ta) skin cancers, family history of melanoma and other skin cancers, presence and number of lentigines in sun-exposed and non-sun-exposed areas, presence and number of nevi on the arms and on the rest of the body; history of prolonged treatments with immunosuppressors; use of tanning beds.
- Occupational History: A detailed, chronological work history. For every job (classified according to the international ISCO-88 classification), the specific job duties, the general company activities, and the country and region (for latitude-based UV index assessment) will be required. If possible, specific dates of job start and job end will be collected, as well as the frequency of use of UVR protective measures (clothing, hat, or sun creams).
- Extra-work solar exposure: The study will investigate the habits of staying outside, frequency of sunburn, going to the sea or to high mountains, and the use of sun protection creams, hats, or UV protective clothing. Data will be separated for holiday time versus free/leisure time, and further divided for the age periods 0-20 and ≥21 years.
Data Management and Analysis:
- Data Handling: All collected data will be anonymized and stored in a secure electronic database (RedCap).
- Exposure Assessment: An expert assessment, guided by a Job Exposure Matrix developed from the EU-funded EPHOR project, will be used to categorize participants' cumulative occupational UVR exposure.
- Statistical Analysis: Standard descriptive statistics will characterize the study population. The association between UVR exposure (both occupational and recreational) and other risk factors for melanoma will be assessed by calculating Odds Ratios (OR) with 95% confidence intervals using multivariate regression analysis. Subgroup analyses will be performed based on melanoma subtype and tumour location. Statistical software such as STATA or SPSS will be used.
Quality Assurance:
The study protocol, including the questionnaire and data management plan, will be standardized. Interviewers will receive specific training to ensure consistent data collection. Data entry will include range and consistency checks to ensure quality.
Ethical Considerations:
The study will be conducted after approval from the relevant Ethical Committee of the University Hospital of Modena. Participation is voluntary, and participants may withdraw at any time without affecting their medical care. For outdoor workers diagnosed with a CSD-related melanoma located on sun-exposed skin, the study procedure includes assistance in reporting the disease to INAIL as a potential occupational illness, as per current Italian recommendations.
- Conditions
- Skin Melanoma, Cutaneous Melanoma
- Keywords
- Skin melanoma, Cutaneous Melanoma, Occupational Exposure, Solar Ultraviolet Radiation, Outdoor Workers, Case-Control Study, Occupational Disease, Skin Cancer, Cumulative Sun Damage, Lentigo Maligna Melanoma, Occupational Health, Dermatology, Italy, Occupational Medicine
- Medical subject headings
- Melanoma, Occupational Diseases, Skin Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Cases | Participants in this group are patients recruited from the Dermatology Clinic who have received a new, histopathologically confirmed diagnosis of skin melanoma. | |
| Controls | Participants in this group are patients recruited from the same Dermatology Clinic who have been screened negative for melanoma. These controls are matched to the cases based on similar age and gender. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Association between occupational solar UVR exposure and melanoma diagnosis.
The strength of the association will be measured by calculating the Odds Ratio (OR) for melanoma in participants with a history of occupational solar UVR exposure compared to those without, using multivariate analysis.
Measured: The Odds Ratio will be calculated and assessed once, at the end of the data collection and analysis phase (at the end of the study).
Secondary outcomes (6)
Association stratified by melanoma subtype.
Analysis of the association (measured by Odds Ratios) between occupational solar UVR exposure and specific melanoma subtypes, classified according to the 2018 WHO criteria (e.g., high Cumulative Solar Damage (CSD) subtypes like Lentigo Maligna Melanoma vs. low-CSD subtypes vs. non-solar subtypes).
Measured: Through study completion, up to 24 months.
Association stratified by tumour location.
Analysis of the association (measured by Odds Ratios) between occupational solar UVR exposure and melanoma occurring on chronically sun-exposed body sites versus less exposed or non-exposed sites.
Measured: Through study completion, up to 24 months.
Proportion of melanoma cases reported as occupational diseases.
The number and proportion of melanoma cases that meet the recent INAIL criteria for being reported as an occupational disease due to solar UVR exposure. This applies to outdoor workers diagnosed with a CSD-related melanoma located on photo-exposed body regions.
Measured: Through study completion, up to 24 months.
Quantitative occupational UVR exposure level computation.
The cumulative occupational solar UVR exposure level for each participant with a history of outdoor work will be estimated using the quantitative European job-exposure matrix (JEM) developed by Würtz et al. Exposure will be expressed in Standard Erythemal Doses (SED).
Measured: Through study completion, up to 24 months.
Individualised melanoma risk score computation.
A quantitative melanoma risk score will be calculated for each participant (both cases and controls) using a risk prediction model developed by Fortes et al. in 2010. This model incorporates known non-occupational risk factors such as skin phototype, hair and eye colour, freckling, family history of melanoma, number of common nevi, and history of sunburns.
Measured: Through study completion, up to 24 months.
Association between quantitative occupational UVR exposure and melanoma risk score.
Analysis of the relationship between the quantitatively estimated occupational UVR exposure (from the JEM) and the individualised melanoma risk score, to investigate potential interactions or confounding.
Measured: Through study completion, up to 24 months.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Nov 2025
- Study start7 Jul 2025
- Primary completionApr 2027 (estimated)
- Study completionNov 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for Skin MelanomaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Modena and Reggio Emilia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Alberto Modenese, University of Modena and Reggio Emilia
- Investigators
- Alberto Modenese, MD. PhD, Principal investigator, University of Modena and Reggio EmiliaFrancesca Farnetani, MD, Study chair, University of Modena and Reggio EmiliaPaola Ferri, MSc, Study director, University of Modena and Reggio EmiliaSergio Rovesti, MD, Study director, University of Modena and Reggio
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07251335
- Sponsor's protocol ID
- FAR_438_2024
- Other IDs
- GRANT_NUMBER: PRJ-0532 FAR2024
- Acronym
- Mesur
- Status last verified
- Oct 2025
- First submitted
- 18 Nov 2025
- Last updated
- 18 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The Individual Participant Data (IPD) collected for this study contains detailed and sensitive personal information, including medical histories, occupational records, and lifestyle factors. To ensure the confidentiality and privacy of our participants in compliance with stringent EU and Italian data protection regulations (GDPR), the data will not be made publicly available. The data will be kept securely within the institutional responsibility of the University of Modena and Reggio Emilia for the purposes outlined in this protocol.
Publications
DECRETO DEL PRESIDENTE DELLA REPUBBLICA 30 giugno 1965, n. 1124. Testo unico delle disposizioni per l'assicurazione obbligatoria contro gli infortuni sul lavoro e le malattie professionali. GU n.257 del 13-10-1965 - Suppl. Ordinario (Ultimo aggiornamento all'atto pubblicato il 18/11/2023)
Armstrong BK, Cust AE. Sun exposure and skin cancer, and the puzzle of cutaneous melanoma: A perspective on Fears et al. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. American Journal of Epidemiology 1977; 105: 420-427. Cancer Epidemiol. 2017 Jun;48:147-156. doi: 10.1016/j.canep.2017.04.004. Epub 2017 May 3.
PubMed 28478931Elder DE, Bastian BC, Cree IA, Massi D, Scolyer RA. The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. Arch Pathol Lab Med. 2020 Apr;144(4):500-522. doi: 10.5858/arpa.2019-0561-RA. Epub 2020 Feb 14.
PubMed 32057276Inail - Sovrintendenza sanitaria centrale: Patrizio Rossi, Grazia Genga Mina. Il melanoma cutaneo professionale da radiazioni solari aspetti d'interesse medico-legale e prevenzionali. ISBN 978-88-7484-825-6
Chiossi R. Melanoma, 270 diagnosi in un anno. Il 70% scoperto in fase precoce. Gazzetta di Modena, 23/5/2023, available online: https://www.gazzettadimodena.it/modena/cronaca/2023/05/23/news/melanoma-270-diagnosi-in-un-anno-il-70-scoperto-in-fase-precoce-1.100310134
Paulo MS, Adam B, Akagwu C, Akparibo I, Al-Rifai RH, Bazrafshan S, Gobba F, Green AC, Ivanov I, Kezic S, Leppink N, Loney T, Modenese A, Pega F, Peters CE, Pruss-Ustun AM, Tenkate T, Ujita Y, Wittlich M, John SM. WHO/ILO work-related burden of disease and injury: Protocol for systematic reviews of occupational exposure to solar ultraviolet radiation and of the effect of occupational exposure to solar ultraviolet radiation on melanoma and non-melanoma skin cancer. Environ Int. 2019 May;126:804-815. doi: 10.1016/j.envint.2018.09.039. Epub 2019 Feb 18.
PubMed 30792021Gobba F, Dall'Olio E, Modenese A, De Maria M, Campi L, Cavallini GM. Work-Related Eye Injuries: A Relevant Health Problem. Main Epidemiological Data from a Highly-Industrialized Area of Northern Italy. Int J Environ Res Public Health. 2017 Jun 6;14(6):604. doi: 10.3390/ijerph14060604.
PubMed 28587288Modenese A, Loney T, Ruggieri FP, Tornese L, Gobba F. Sun protection habits and behaviors of a group of outdoor workers and students from the agricultural and construction sectors in north-Italy. Med Lav. 2020 Apr 30;111(2):116-125. doi: 10.23749/mdl.v111i2.8929.
PubMed 32352425Modenese A, Farnetani F, Andreoli A, Pellacani G, Gobba F. Questionnaire-based evaluation of occupational and non-occupational solar radiation exposure in a sample of Italian patients treated for actinic keratosis and other non-melanoma skin cancers. J Eur Acad Dermatol Venereol. 2016 Apr;30 Suppl 3:21-6. doi: 10.1111/jdv.13606.
PubMed 26995019Wurtz ET, Pugdahl K, Fenger-Gron M, Berglind IA, Cherrie MPC, Dahlman-Hoglund A, Grandahl K, Macan J, Modenese A, Noto H, Solovieva S, Straif K, Wittlich M, Connemann S, Heepenstrick T, Philipsen PA, Westerhausen S, Ge CB, Hansen J, Peters CE, Mehlum IS, Schlunssen V, Kolstad HA. A quantitative solar ultraviolet radiation job-exposure matrix for Europe. Ann Work Expo Health. 2025 Apr 24;69(4):415-428. doi: 10.1093/annweh/wxaf011.
PubMed 40056460
Study at a glance
From the registry record, last updated by the sponsor on 18 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active Search and Prevention of Occupational Diseases Based on Recent INAIL Criteria
- ClinicalTrials.gov ID
- NCT07251335
- Acronym / sponsor ID
- Mesur / FAR_438_2024
- Conditions
- Skin Melanoma, Cutaneous Melanoma
- Keywords
- Skin melanoma, Cutaneous Melanoma, Occupational Exposure, Solar Ultraviolet Radiation, Outdoor Workers, Case-Control Study, Occupational Disease, Skin Cancer
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- University of Modena and Reggio EmiliaUniversity, hospital or other
- Study start
- 7 Jul 2025 (actual)
- Primary completion
- Apr 2027 (estimated)
- Study completion
- Nov 2027 (estimated)
- First posted
- 26 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to learn about the link between work-related sun exposure and a specific type of skin cancer called melanoma in people living in the Modena area, Italy.
The main questions it aims to answer are:
- Is there a connection between working outdoors and developing types of melanoma that are linked to long-term sun exposure?
- Can we use recent criteria from the Italian workers' compensation authority (Istituto Nazionale per l'Assicurazione contro gli Infortuni sul Lavoro, INAIL) to better identify and report these melanomas as occupational diseases?
Participants in this study will:
- Be patients of the Modena University Hospital Dermatology Clinic who are already undergoing a skin biopsy for a suspected lesion.
- Take part in a one-time interview with a trained healthcare worker.
Answer questions about their:
- Job history and specific work locations (to calculate local UVR exposure).
- Sun exposure habits at work and in their free/holiday time.
- Use of sun protection (e.g., sunscreen, protective clothing).
- Use of tanning beds.
- Natural skin color and tendency to sunburn (and other elements to determine their specific skin phototype).
- Other personal and family health factors.
Researchers will compare two groups:
- Cases: 120 participants who are diagnosed with melanoma after the biopsy.
- Controls: 180 participants who screened negative for melanoma but may show another skin condition.
By comparing these groups, researchers aim at better understanding the role of outdoor work as a risk factor for specific melanoma subtypes. For participants diagnosed with a melanoma that is likely linked to their job, the study team will promote its reporting as an occupational disease.
Detailed description
This is a monocentric, observational, case-control study conducted at the Dermatology Clinic of the University Hospital of Modena (Azienda Ospedaliero-Universitaria di Modena), Italy.
Background and Rationale:
Skin melanoma is a significant public health concern. While its link to solar ultraviolet radiation (UVR) is established, the specific role of occupational (long-term, cumulative) exposure, as opposed to recreational (intermittent, intense) exposure, is still a subject of detailed investigation. In the period 2008-2014, skin melanoma was included in List 2 (limited probability of occupational origin) of diseases to be mandatorily reported as "occupational" by physicians (Italian law DPR 1124/1965) for the exposure agent "solar radiation". After 2014, it was removed from that list, partly due to evolving scientific evidence suggesting that UV-related malignant melanoma was more strongly related to a pattern of solar ultraviolet radiation exposure typically associated with leisure time activities rather than occupational outdoor activities, especially during childhood and adolescence. Recent classifications by the World Health Organization (WHO) now distinguish melanoma subtypes based on their association with cumulative solar damage (CSD). This is a crucial development, as occupational outdoor activity is a primary factor associated with cumulative sun damage. A joint WHO/International Labour Organization (ILO) meta-analysis found a significantly increased risk for one specific CSD-related subtype, Lentigo Maligna Melanoma, in outdoor workers. In line with this, the Italian National Institute for Insurance against Accidents at Work (Istituto Nazionale per l'Assicurazione contro gli Infortuni sul Lavoro, INAIL) has recently proposed new criteria for recognizing specific CSD-related melanomas as occupational diseases in this worker population.
This study aims to apply these novel criteria in a clinical setting to investigate the association between occupational UVR exposure and CSD-related melanoma subtypes.
Study Objectives:
- The primary objective is to evaluate the association between occupational solar UVR exposure and the risk of developing melanoma, with a specific focus on subtypes related to cumulative solar damage (CSD).
Secondary objectives include:
- Comparing occupational and recreational UVR exposure patterns between melanoma cases and controls.
- Correlating melanoma subtypes (CSD-related vs. non-CSD-related) and their body location with specific UVR exposure histories.
- Applying the recent INAIL criteria to identify cases of melanoma that qualify for reporting as occupational diseases.
- Quantitatively estimating individual occupational UVR exposure levels by applying a validated European job-exposure matrix (JEM) developed by Würtz et al. in 2025.
- Calculating and comparing an individualised melanoma risk score for each participant, based on established non-occupational risk factors, according to the model developed and externally validated by Fortes et al. in 2010.
- Analysing the relationship between quantitative occupational UVR exposure and the individualised melanoma risk score.
Study Population and Recruitment:
The study population will consist of patients referred to the Dermatology Clinic for examination of suspicious skin lesions. All enrolled participants will provide written informed consent.
Cases: Approximately 120 adult patients (≥18 years) with a new, histopathologically confirmed diagnosis of cutaneous melanoma.
Controls: Approximately 180 adult patients (≥18 years) who undergo a dermatological screening for a suspicious lesion, but for whom the result of the screening is negative for melanoma. These controls will be matched to cases based on similar age and gender to minimize confounding.
Methods:
Data Collection: After enrolment, all participants (cases and controls) will undergo a single, structured interview conducted by trained healthcare personnel (e.g., resident physicians). The interview will use a detailed questionnaire designed specifically for this study based on a comprehensive literature review.
Questionnaire Content: The questionnaire will collect data on:
- Socio-demographics and general information: Age, gender, country of birth, smoking habits, physical characteristics linked to determine phototype, ease of sunburn, residential history.
- Dermatological anamnesis: Skin melanoma diagnosis, type of melanoma, location, past diagnosis of skin melanoma(ta) and location, past diagnosis of non-melanoma(ta) skin cancers, family history of melanoma and other skin cancers, presence and number of lentigines in sun-exposed and non-sun-exposed areas, presence and number of nevi on the arms and on the rest of the body; history of prolonged treatments with immunosuppressors; use of tanning beds.
- Occupational History: A detailed, chronological work history. For every job (classified according to the international ISCO-88 classification), the specific job duties, the general company activities, and the country and region (for latitude-based UV index assessment) will be required. If possible, specific dates of job start and job end will be collected, as well as the frequency of use of UVR protective measures (clothing, hat, or sun creams).
- Extra-work solar exposure: The study will investigate the habits of staying outside, frequency of sunburn, going to the sea or to high mountains, and the use of sun protection creams, hats, or UV protective clothing. Data will be separated for holiday time versus free/leisure time, and further divided for the age periods 0-20 and ≥21 years.
Data Management and Analysis:
- Data Handling: All collected data will be anonymized and stored in a secure electronic database (RedCap).
- Exposure Assessment: An expert assessment, guided by a Job Exposure Matrix developed from the EU-funded EPHOR project, will be used to categorize participants' cumulative occupational UVR exposure.
- Statistical Analysis: Standard descriptive statistics will characterize the study population. The association between UVR exposure (both occupational and recreational) and other risk factors for melanoma will be assessed by calculating Odds Ratios (OR) with 95% confidence intervals using multivariate regression analysis. Subgroup analyses will be performed based on melanoma subtype and tumour location. Statistical software such as STATA or SPSS will be used.
Quality Assurance:
The study protocol, including the questionnaire and data management plan, will be standardized. Interviewers will receive specific training to ensure consistent data collection. Data entry will include range and consistency checks to ensure quality.
Ethical Considerations:
The study will be conducted after approval from the relevant Ethical Committee of the University Hospital of Modena. Participation is voluntary, and participants may withdraw at any time without affecting their medical care. For outdoor workers diagnosed with a CSD-related melanoma located on sun-exposed skin, the study procedure includes assistance in reporting the disease to INAIL as a potential occupational illness, as per current Italian recommendations.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Cases | – | –Participants in this group are patients recruited from the Dermatology Clinic who have received a new, histopathologically confirmed diagnosis of skin melanoma. |
| Controls | – | –Participants in this group are patients recruited from the same Dermatology Clinic who have been screened negative for melanoma. These controls are matched to the cases based on similar age and gender. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population will be selected from the patient cohort attending the Dermatology Clinic of the University Hospital of Modena (Azienda Ospedaliero-Universitaria di Modena), Italy. This clinic serves a large number of citizens from the Modena province and surrounding areas each year, providing a representative sample for investigating skin cancer. Participants will be identified from among those referred to the clinic for the examination and diagnosis of suspicious pigmented skin lesions.
Key inclusion criteria (4 listed)
- Be a patient of the Dermatology Clinic at the University Hospital of Modena.
- Be 18 years of age or older.
- Have undergone a dermatological screening for a suspected skin lesion.
- Be able to understand and sign an informed consent form in italian language.
Key exclusion criteria (2 listed)
- Be under 18 years of age.
- Have cognitive impairment that prevents providing reliable answers to the interview or recalling past exposures.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Association between occupational solar UVR exposure and melanoma diagnosis.
Time frame: The Odds Ratio will be calculated and assessed once, at the end of the data collection and analysis phase (at the end of the study).
The strength of the association will be measured by calculating the Odds Ratio (OR) for melanoma in participants with a history of occupational solar UVR exposure compared to those without, using multivariate analysis.
6 secondary outcomes
Association stratified by melanoma subtype.
Time frame: Through study completion, up to 24 months.
Association stratified by tumour location.
Time frame: Through study completion, up to 24 months.
Proportion of melanoma cases reported as occupational diseases.
Time frame: Through study completion, up to 24 months.
Quantitative occupational UVR exposure level computation.
Time frame: Through study completion, up to 24 months.
Individualised melanoma risk score computation.
Time frame: Through study completion, up to 24 months.
Association between quantitative occupational UVR exposure and melanoma risk score.
Time frame: Through study completion, up to 24 months.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Dec 2025.
- Results publicationDECRETO DEL PRESIDENTE DELLA REPUBBLICA 30 giugno 1965, n. 1124. Testo unico delle disposizioni per l'assicurazione obbligatoria contro gli infortuni sul lavoro e le malattie professionali. GU n.257 del 13-10-1965 - Suppl. Ordinario (Ultimo aggiornamento all'atto pubblicato il 18/11/2023)
- Results publication: PubMed 28478931Armstrong BK, Cust AE. Sun exposure and skin cancer, and the puzzle of cutaneous melanoma: A perspective on Fears et al. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. American Journal of Epidemiology 1977; 105: 420-427. Cancer Epidemiol. 2017 Jun;48:147-156. doi: 10.1016/j.canep.2017.04.004. Epub 2017 May 3.
- Results publication: PubMed 32057276Elder DE, Bastian BC, Cree IA, Massi D, Scolyer RA. The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. Arch Pathol Lab Med. 2020 Apr;144(4):500-522. doi: 10.5858/arpa.2019-0561-RA. Epub 2020 Feb 14.
- Results publicationInail - Sovrintendenza sanitaria centrale: Patrizio Rossi, Grazia Genga Mina. Il melanoma cutaneo professionale da radiazioni solari aspetti d'interesse medico-legale e prevenzionali. ISBN 978-88-7484-825-6
- Results publicationChiossi R. Melanoma, 270 diagnosi in un anno. Il 70% scoperto in fase precoce. Gazzetta di Modena, 23/5/2023, available online: https://www.gazzettadimodena.it/modena/cronaca/2023/05/23/news/melanoma-270-diagnosi-in-un-anno-il-70-scoperto-in-fase-precoce-1.100310134
- Results publication: PubMed 30792021Paulo MS, Adam B, Akagwu C, Akparibo I, Al-Rifai RH, Bazrafshan S, Gobba F, Green AC, Ivanov I, Kezic S, Leppink N, Loney T, Modenese A, Pega F, Peters CE, Pruss-Ustun AM, Tenkate T, Ujita Y, Wittlich M, John SM. WHO/ILO work-related burden of disease and injury: Protocol for systematic reviews of occupational exposure to solar ultraviolet radiation and of the effect of occupational exposure to solar ultraviolet radiation on melanoma and non-melanoma skin cancer. Environ Int. 2019 May;126:804-815. doi: 10.1016/j.envint.2018.09.039. Epub 2019 Feb 18.
- Results publication: PubMed 28587288Gobba F, Dall'Olio E, Modenese A, De Maria M, Campi L, Cavallini GM. Work-Related Eye Injuries: A Relevant Health Problem. Main Epidemiological Data from a Highly-Industrialized Area of Northern Italy. Int J Environ Res Public Health. 2017 Jun 6;14(6):604. doi: 10.3390/ijerph14060604.
- Results publication: PubMed 32352425Modenese A, Loney T, Ruggieri FP, Tornese L, Gobba F. Sun protection habits and behaviors of a group of outdoor workers and students from the agricultural and construction sectors in north-Italy. Med Lav. 2020 Apr 30;111(2):116-125. doi: 10.23749/mdl.v111i2.8929.
- Results publication: PubMed 26995019Modenese A, Farnetani F, Andreoli A, Pellacani G, Gobba F. Questionnaire-based evaluation of occupational and non-occupational solar radiation exposure in a sample of Italian patients treated for actinic keratosis and other non-melanoma skin cancers. J Eur Acad Dermatol Venereol. 2016 Apr;30 Suppl 3:21-6. doi: 10.1111/jdv.13606.
- Results publication: PubMed 40056460Wurtz ET, Pugdahl K, Fenger-Gron M, Berglind IA, Cherrie MPC, Dahlman-Hoglund A, Grandahl K, Macan J, Modenese A, Noto H, Solovieva S, Straif K, Wittlich M, Connemann S, Heepenstrick T, Philipsen PA, Westerhausen S, Ge CB, Hansen J, Peters CE, Mehlum IS, Schlunssen V, Kolstad HA. A quantitative solar ultraviolet radiation job-exposure matrix for Europe. Ann Work Expo Health. 2025 Apr 24;69(4):415-428. doi: 10.1093/annweh/wxaf011.
- Individual participant dataSharing planned: No. The Individual Participant Data (IPD) collected for this study contains detailed and sensitive personal information, including medical histories, occupational records, and lifestyle factors. To ensure the confidentiality and privacy of our participants in compliance with stringent EU and Italian data protection regulations (GDPR), the data will not be made publicly available. The data will be kept securely within the institutional responsibility of the University of Modena and Reggio Emilia for the purposes outlined in this protocol.
Related trials for Skin Melanoma
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingPhase 1
IL-17 Blockade to Decrease irAEs (REPLAY)
Metastatic Melanoma
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 1
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
Melanoma
Active, not recruitingPhase 1/2
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
Melanoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Alberto Modenese, MD. PhD principal investigator
University of Modena and Reggio Emilia
Francesca Farnetani, MD study chair
University of Modena and Reggio Emilia
Paola Ferri, MSc study director
University of Modena and Reggio Emilia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Skin Melanoma and Cutaneous Melanoma, run by University of Modena and Reggio Emilia at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 18 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Alberto Modenese, MD, PhD (+39 059 205 5461, alberto.modenese@unimore.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Association between occupational solar UVR exposure and melanoma diagnosis. (time frame: The Odds Ratio will be calculated and assessed once, at the end of the data collection and analysis phase (at the end of the study).). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07251335, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2025.